Market News Archive
Stay updated with the latest announcements
ICBAMCL2ND: Weekly NAV
On the close of operation on 15-Oct-2024, the Fund has reported Net Asset Value (NAV) of Tk. 8.21 per unit on the basis of current market price and Tk. 13.84 per unit on the basis of cost price against face value of Tk. 10.00 whereas total Net Assets of the Fund stood at Tk. 410,702,961.67 on the basis of current market price and Tk. 692,076,801.19 on the basis of cost price after considering all assets and liabilities of the Fund.
1STPRIMFMF: Weekly NAV
On the close of operation on 15-Oct-2024, the Fund has reported Net Asset Value (NAV) of Tk. 9.26 per unit on the basis of current market price and Tk. 17.86 per unit on the basis of cost price against face value of Tk. 10.00 whereas total Net Assets of the Fund stood at Tk. 185,287,813.15 on the basis of current market price and Tk. 357,285,840.16 on the basis of cost price after considering all assets and liabilities of the Fund.
IBP: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2024 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
AZIZPIPES: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 26, 2024 at 11:30 AM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2024.
RENATA: Launching of the first generic version of Cabergoline 0.5mg in Australia
The company has informed that it has successfully dispatched its first shipment of the generic version of Cabergoline 0.5mg in Australia. The medicine is an effective treatment for Hyperprolactinemia and Parkinson's disease. The distribution and commercialization of Cabergoline, marketed under the brand name Dostamine, will be facilitated in Australia through Renata's partner, Nova Pharmaceuticals Australasia Pty Ltd.
AZIZPIPES: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 26, 2024 at 11:30 AM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
BBSCABLES: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 26, 2024 at 2:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
FARCHEM: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 24, 2024 at 4:30 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
DSENEWS: Stock-Broker & Stock-Dealer Registration
Trade X Securities Ltd. (DSE TREC No. 280) has been issued Stock-Broker Registration Certificate No. Reg.-3.1/DSE-280/2024/679, dated April 08, 2024 and Stock-Dealer Registration Certificate No.: Reg.-3.1/DSE-280/2024/678, dated April 08, 2024. The broker and dealer trading code of the company are TDX and DLRTDX respectively.
GHAIL: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2024 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
MHSML: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2024 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
NTC: Extension of time for subscription of the proposed capital raising
The company has informed that Bangladesh Securities and Exchange Commission has accorded its consent to the company for an extension of time up to 31 March, 2025 for raising of capital of Tk. 279,70,02,000.00 only through issuance of 2,34,00,000 ordinary shares of Tk. 119.53 each only to the existing shareholders of the company on record date in cash consideration. It is to be mentioned here that the company shall have to ensure the compliance (cont.)
DULAMIACOT: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 27, 2024 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
SBACBANK: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 22, 2024 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended September 30, 2024.
NRBBANK: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 23, 2024 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended September 30, 2024.
ILFSL: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 24, 2024 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended September 30, 2024.
DSHGARME: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2024 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
BBS: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 26, 2024 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
CONTININS: Sale Declaration of a Sponsor
Mrs. Dolly Iqbal, a Sponsor of the Company, has expressed her intention to sell 8,33,402 shares out of her total holding of 8,75,072 shares of the company at prevailing market price (in the Block Market) through Dhaka Stock Exchange PLC., whereas Mr. Kazi Joynuddin Ifthekhar will buy the aforementioned 8,33,402 shares (the Board of Directors has decided to appoint him as a Director of the company after completion of the purchase) within October 31, 2024.
LEGACYFOOT: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2024 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.